For example, according to the FTC’s lawsuit, in 1999, the average list price of a brand-name insulin, Humalog, was only $21.

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

Insulin lispro, the rapid-acting component of Humalog Mix75/25, has been shown to be equipotent to Regular human insulin on a molar basis. Instruct patients on diet, exercise, blood or urine ...

(KKTV) - A shortage of Eli Lilly insulin products continues to put Southern Colorado residents in a bind. The company announced last month that their 10-milliliter vials of Humalog and Insulin ...

For example, according to the FTC’s lawsuit, in 1999, the average list price of a brand-name insulin, Humalog, was only $21. Less than 20 years later, in 2017, it increased to more than $274 ...

Two decades later, Ms Marston still uses the same formula of insulin - Eli Lilly's Humalog. Even the packaging is the same. "Nothing about it has changed, except the price has gone up from $21 a ...

Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro ...

This March 1, 2023, photo shows a vial of Eli Lilly's Humalog insulin in New York. (AP Photo/Pablo Salinas) LOS ANGELES (CN) — A Superior Court judge, on Tuesday, told lawyers for the state of ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...